title: A maxillary mass in a HBV-cirrhotic patient.
authors.affiliation: Storr Liver Unit, Westmead Hospital, Sydney, Australia.
authors.forename: Vi
authors.initials: V
authors.lastname: Nguyen
authors.forename: Jacob
authors.initials: J
authors.lastname: George
authors.forename: David
authors.initials: D
authors.lastname: van der Poorten
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001557:Benzenesulfonates / Q000008:administration & dosage; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D006528:Carcinoma, Hepatocellular / Q000737:chemistry / Q000556:secondary* / Q000628:therapy / Q000821:virology; D017024:Chemotherapy, Adjuvant; D006498:Hepatectomy; D019694:Hepatitis B, Chronic / Q000150:complications*; D006801:Humans; D007150:Immunohistochemistry; D008103:Liver Cirrhosis / Q000821:virology*; D008113:Liver Neoplasms / Q000737:chemistry / Q000473:pathology* / Q000628:therapy / Q000821:virology; D008297:Male; D008441:Maxillary Neoplasms / Q000737:chemistry / Q000556:secondary* / Q000601:surgery; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage; D011725:Pyridines / Q000008:administration & dosage; D000077157:Sorafenib; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D014408:Biomarkers, Tumor; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib